Rie Onose
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
-
- Angiogenesis and VEGF in Cancer 4
- Cancer therapeutics and mechanisms 4
- Ubiquitin and proteasome pathways 3
- Cell death mechanisms and regulation 3
- 14-3-3 protein interactions 2
- Pharmacology 10
- Microbial Natural Products and Biosynthesis 9
- Co-authors
- Hiroyuki Osada (20 shared papers)Hideaki Kakeya (15 shared papers)Cheng‐Bin Cui (2 shared papers)Gen Okada (3 shared papers)Hiroyuki Koshino (7 shared papers)Yukihiro Asami (3 shared papers)Hideo Osada (1 shared paper)Hiroshi Matsuzaki (3 shared papers)
In The Last Decade
Rie Onose
24 papers receiving 899 citations
Peers
Comparison fields: 5 of 69
- Toxicology 60
- Pharmacology 272
- Biotechnology 132
- Organic Chemistry 402
- Cell Biology 115
Countries citing papers authored by Rie Onose
This map shows the geographic impact of Rie Onose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rie Onose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rie Onose more than expected).
Fields of papers citing papers by Rie Onose
This network shows the impact of papers produced by Rie Onose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rie Onose. The network helps show where Rie Onose may publish in the future.
Co-authors
The 25 scholars most cited alongside Rie Onose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 185 | |
| 2 | 2002 | 119 | |
| 3 | 2002 | 91 | |
| 4 | 2002 | 80 | |
| 5 | Caspase-mediated activation of a 36-kDa myelin basic protein kinase during anticancer drug-induced apoptosis. | 1998 | 67 |
| 6 | 1992 | 50 | |
| 7 | 2006 | 47 | |
| 8 | 1997 | 46 | |
| 9 | 2000 | 35 | |
| 10 | 1992 | 35 | |
| 11 | 2004 | 21 | |
| 12 | 2005 | 20 | |
| 13 | 2005 | 19 | |
| 14 | 1992 | 17 | |
| 15 | Inhibition of cyclin D1 expression and phosphorylation of retinoblastoma protein by phosmidosine, a nucleotide antibiotic. | 1998 | 16 |
| 16 | 1997 | 15 | |
| 17 | 1996 | 15 | |
| 18 | 1992 | 14 | |
| 19 | 2001 | 13 | |
| 20 | Aspergillus fumigatusが生産するほ乳動物細胞周期の新規抑制剤トリプロスタチンA,Bと他のジケトピペラジン類 1 分類,発酵,単離と生物学的性質 | 1996 | 9 |
About Rie Onose
Rie Onose is a scholar working on Molecular Biology, Pharmacology, Oncology, Organic Chemistry and Biotechnology, having authored 24 papers that have together received 925 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (9 papers), Cancer Treatment and Pharmacology (5 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer therapeutics and mechanisms (4 papers), Ubiquitin and proteasome pathways (3 papers), Cell death mechanisms and regulation (3 papers), 14-3-3 protein interactions (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Toxicology (60 citations), Pharmacology (272 citations), Biotechnology (132 citations), Organic Chemistry (402 citations) and Cell Biology (115 citations). Rie Onose has collaborated with scholars based in Japan, Belarus and Iran. Frequent co-authors include Hiroyuki Osada, Hideaki Kakeya, Cheng‐Bin Cui, Gen Okada, Hiroyuki Koshino, Yukihiro Asami, Hideo Osada, Hiroshi Matsuzaki, Kiyoshi Isono and Naoko Takahashi. Their work appears in journals such as The Journal of Antibiotics, Tetrahedron, Bioscience Biotechnology and Biochemistry, Experimental Cell Research and Chemistry - An Asian Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.